Bone Cancer Breakthrough: UCL’s New T-Cell Therapy Shows Promise

  • 📰 SciTechDaily1
  • ⏱ Reading Time:
  • 42 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 20%
  • Publisher: 68%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

Science, Space and Technology News 2024

Researchers at UCL have developed a promising new immunotherapy using gamma-delta T cells for osteosarcoma and other bone metastases, showing significant preclinical success. This innovative approach, termed OPS-gdT, is set to enter early-phase clinical trials after demonstrating its potential to effectively control tumor growth in mouse models. Credit: SciTechDaily.com

Cancer that starts in or spreads to the bones is particularly hard to treat, meaning that it is a leading cause of cancer-related death. It is also frequently resistant to chemotherapy, so new treatments are needed., found that using a small subset of immune cells, called gamma-delta T cells could provide an efficient and cost-effective solution.

“An alternative is to use an ‘off the shelf’ treatment made from healthy donor immune cells, but in order to do this care must be taken to avoid graft-versus-host disease, where the donor immune cells attack the patient’s body. Dr. Fisher said: “Thousands upon thousands of people have cancer that spreads to the bones. There is currently very little that can be done to cure these patients. However, this is an exciting step forward in finding a potential new treatment.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 84. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Ipilimumab, a Pioneer Breakthrough in Cancer TreatmentI am a scientist, businessman, author, and philanthropist. For nearly two decades, I was a professor at Harvard Medical School and Harvard School of Public Health where I founded two academic research departments, the Division of Biochemical Pharmacology and the Division of Human Retrovirology.
Source: ForbesTech - 🏆 318. / 59 Read more »

Conquering cancer: Cleveland Marathon runner turned cancer patient shares survival storyJohn Johnson is an avid runner. He spent countless hours training for last year’s Cleveland Marathon.
Source: cleveland19news - 🏆 70. / 68 Read more »

Mother rings 'Cancer Bell' to celebrate victory over ovarian cancerAutumn Gray gathered with family, friends, and medical team at Kaiser Permanente Oncology Unit.
Source: CBS8 - 🏆 335. / 59 Read more »

Treating colorectal cancer with personalized care at Mays Cancer CenterSPONSORED: Treatment plans are as individual as the patient. At Mays Cancer Center, a multidisciplinary team devises a personalized treatment strategy.
Source: SAReport - 🏆 252. / 63 Read more »

Mammograms should start at 40, panel says, as breast cancer rates rise in younger womenBreast cancer is still the second-most common cause of cancer death for U.S. women.
Source: mercnews - 🏆 88. / 68 Read more »